Authors:
AHONEN A
KOSKINEN R
RANTANEN P
BILLHEDEN J
BRATHEN G
BRIEM H
CRONBERG S
HAIDL S
ELMRUD H
BANKE S
FORSBERG P
HANNINEN P
HEDSTROM SA
ERNTELL M
LAHDEVIRTA J
HAKULINEN A
SIIKAMAKI H
LINDAHL L
NERINGER R
EKLUND PO
NORRBY SR
SCHLIAMSER SE
PERMIN H
SALMI HA
GERLINPIIRA L
KLEMETS P
LINDHOLM L
POLLONEN MP
ROSENGREN LM
SINASALO JP
TAKAL A
YLIAPALOSAARI P
SEEFELDTNIELSEN T
TARP B
SODERSTROM C
TAURIS P
TIKKINEN J
WALSTAD RA
THOMASSEN T
Citation: A. Ahonen et al., ATYPICAL PNEUMONIA IN THE NORDIC COUNTRIES - ETIOLOGY AND CLINICAL-RESULTS OF A TRIAL COMPARING FLEROXACIN AND DOXYCYCLINE, Journal of antimicrobial chemotherapy, 39(4), 1997, pp. 499-508
Citation: S. Funiak et al., VON-WILLEBRAND-FACTOR AND ENDOTHELIAL DAMAGE IN ESSENTIAL-HYPERTENSION, Journal of human hypertension, 9(8), 1995, pp. 705-705
Authors:
CRONBERG S
BANKE S
BRUNO AM
CARLSSON M
ELMRUD H
ELOWSSON S
JOSEFSSON K
LINDHOLM AC
MONTELIUS H
NERINGER R
ODE B
STENLUND G
SVANTESON B
THOREN A
WALDER M
WALLMARK E
Citation: S. Cronberg et al., AMPICILLIN PLUS MECILLINAM VS CEFOTAXIME CEFADROXIL TREATMENT OF PATIENTS WITH SEVERE PNEUMONIA OR PYELONEPHRITIS - A DOUBLE-BLIND MULTICENTER STUDY EVALUATED BY INTENTION-TO-TREAT ANALYSIS/, Scandinavian journal of infectious diseases, 27(5), 1995, pp. 463-468
Citation: S. Cronberg, ANTIMICROBIAL PRACTICE - SIMPLIFIED MONITORING OF AMINOGLYCOSIDES, Journal of antimicrobial chemotherapy, 34(5), 1994, pp. 819-827